Current Diagnostic Modalities for Vulnerable Plaque Detection

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|10|995-1001

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.10, 2007-04, pp. : 995-1001

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The vulnerable atherosclerotic plaque

By Suckling K.E.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 121-134

Informa Healthcare

Access to resources Recommend Favorite

Biomarkers Associated with Vulnerable Atheromatous Plaque

By  

Current Medicinal Chemistry, Vol. 19, Iss. 16, 2012-06 ,pp. : 2588-2596

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinases and Vulnerable Atheromatous Plaque

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-05 ,pp. : 1166-1180

Bentham Science Publishers

Access to resources Recommend Favorite

Vulnerable Plaque Versus Vulnerable Patient: Emerging Blood Biomarkers for Risk Stratification

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 3, 2007-09 ,pp. : 195-201

Bentham Science Publishers

Access to resources Recommend Favorite

Pleiotropic Effects of Statins: Stabilization of the Vulnerable Atherosclerotic Plaque?

By  

Current Pharmaceutical Design, Vol. 13, Iss. 10, 2007-04 ,pp. : 1003-1012

Bentham Science Publishers

Access to resources Recommend Favorite